Qiagen N.V.
General ticker "QGEN" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $9.8B (TTM average)
Qiagen N.V. follows the US Stock Market performance with the rate: 50.4%.
Estimated limits based on current volatility of 1.9%: low 47.43$, high 49.22$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-07-02, amount 0.25$ (Y0.53%)
- Total employees count: 328 as of 2001
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [36.20$, 54.54$]
- 2025-12-31 to 2026-12-31 estimated range: [38.04$, 56.87$]
Short-term QGEN quotes
Long-term QGEN plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $1,978.21MM |
| Operating Expenses | $1,880.50MM |
| Operating Income | $97.71MM |
| Non-Operating Income | $23.44MM |
| Interest Expense | $43.84MM |
| R&D Expense | $193.49MM |
| Income(Loss) | $121.15MM |
| Taxes | $37.56MM |
| Profit(Loss)* | $83.59MM |
| Stockholders Equity | $3,567.34MM |
| Inventory | $279.26MM |
| Assets | $5,689.62MM |
| Operating Cash Flow | $673.55MM |
| Capital expenditure | $167.17MM |
| Investing Cash Flow | $-249.23MM |
| Financing Cash Flow | $-422.90MM |
| Earnings Per Share** | $0.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.